http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11848156

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, P.H.S.
endingPage 762
issn 1058-4838
1537-6591
issueIdentifier 6
pageRange 760-762
publicationName Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
startingPage 760
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e423e98d115894f5b30465dcb1113e0c
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_266f09c09d1e3aa97cbfe9240f44f32b
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_21b3610c5d2dd5db095455adc5aeb1b9
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a3876a44e7d9b58815ea5ebe98de6dfe
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_30df1f382a8a0c81633eceefe55661dc
bibliographicCitation Chaudry NI, Eron JJ, Naderer OJ, Pereira AS, Wire MB, Fiscus SA, Kashuba AD. Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected men. Clin Infect Dis. 2002 Sep 15;35(6):760–2. doi: 10.1086/342389. PMID: 12203175.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c44c0c99c61e78d46c0d2c3fa9ca63da
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e737e64abd5ad7b7ab2f306e36f87d0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b514a1dfb11293b34157561270a24fb8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_596fd514355e74c46553711e510a4ea6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4286037760c9640666ff72cd72f72938
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e35cdc1db844c5c46e1a40a5698c071b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09f62fdd4c26ee83f198822ec9c917d5
date 2002-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/12203175
https://doi.org/10.1086/342389
isPartOf https://portal.issn.org/resource/ISSN/1537-6591
https://portal.issn.org/resource/ISSN/1058-4838
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1135
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Effects of Formulation and Dosing Strategy on Amprenavir Concentrations in the Seminal Plasma of Human Immunodeficiency Virus Type 1–Infected Men
discusses http://id.nlm.nih.gov/mesh/M0017642
http://id.nlm.nih.gov/mesh/M0028918
http://id.nlm.nih.gov/mesh/M0003327
http://id.nlm.nih.gov/mesh/M0020790
http://id.nlm.nih.gov/mesh/M0250495
http://id.nlm.nih.gov/mesh/M0008898
http://id.nlm.nih.gov/mesh/M0468017
http://id.nlm.nih.gov/mesh/M0028839
http://id.nlm.nih.gov/mesh/M0388439
http://id.nlm.nih.gov/mesh/M0026300
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D013449Q000097
http://id.nlm.nih.gov/mesh/D010755
http://id.nlm.nih.gov/mesh/D015658Q000097
http://id.nlm.nih.gov/mesh/D019380Q000097
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005663
http://id.nlm.nih.gov/mesh/D012661Q000378
http://id.nlm.nih.gov/mesh/D017320Q000097
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D015497Q000187
http://id.nlm.nih.gov/mesh/D011355Q000493
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D002219
http://id.nlm.nih.gov/mesh/D019438Q000097
http://id.nlm.nih.gov/mesh/D002626
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136139133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129815097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681033

Total number of triples: 64.